Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, T Nose, Shinya Ohata, Yoshiaki Nagatani, Taiji Koyama, Akihito Kitao, Meiko Nishimura, Yoshinori Imamura, Naomi Kiyota, Kenichi Harada, Yugo Tanaka, Yasuko Mori, Hironobu Minami
Topics & Concepts
ImmunogenicityMedicineAdverse effectVaccinationCancerInternal medicineChemotherapyTiterImmunotherapyAntibodyAntibody titerImmune systemImmunologyCoronavirus disease 2019 (COVID-19)OncologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchLymphadenopathy Diagnosis and AnalysisImmunotherapy and Immune Responses